Tidal Therapeutics is a preclinical biotech company focused on developing nanoparticles that deliver mRNA to reprogram immune cells inside the body with applications in oncology and immune diseases.
- Year invested 2019
- Investment Stage Early
- Sectors
- Investment Status Current
- Associated Team
- Company Status Acquired (by Sanofi)